| Drug Name |
Omega-3-acid ethyl esters |
| Drug ID |
BADD_D01611 |
| Description |
Omega-3-acid ethyl esters are prescription drugs that contain eicosapentaenoic acid-ethyl ester (EPA) and docosahexaenoic acid-ethyl ester (DHA) that are used in combination with changes in diet to lower triglyceride levels in adults with severe (≥ 500 mg/dL) hypertriglyceridemia[FDA Label][A176687]. Omega-3-acid ethyl esters are currently marketed in the US, EU, and many other regions under the brand name Lovaza[FDA Label][L5849]. |
| Indications and Usage |
Omega-3-Acid Ethyl Esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia (HTG). |
| Marketing Status |
Prescription |
| ATC Code |
Not Available |
| DrugBank ID |
DB09539
|
| KEGG ID |
D05255
|
| MeSH ID |
Not Available
|
| PubChem ID |
9831414
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
69452-175; 55700-873; 72189-024; 60505-4462; 61474-4264; 69784-420; 10888-5022; 31722-936; 62559-410; 58135-001; 10888-5038; 60897-150; 71335-2024; 70518-1636; 65162-034; 60687-127; 63629-2448; 63629-2451; 72998-850; 42291-657; 11014-0200; 42708-067; 64380-761; 0904-6706; 50090-3421; 50090-3956; 68197-0003; 50090-5799; 42806-552; 50090-3742; 50090-3957; 0254-3010; 44585-0004; 68197-8503; 63629-1918; 70518-3040; 50268-676; 72865-139; 60505-3170 |
| Synonyms |
Not Available |
